Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis
- PMID: 23228945
- PMCID: PMC3578035
- DOI: 10.1053/j.ajkd.2012.10.016
Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis
Abstract
Background: Urinary liver-type fatty acid-binding protein (L-FABP) is a proximal tubular injury candidate biomarker for early detection of acute kidney injury (AKI), with variable performance characteristics depending on clinical settings.
Study design: Meta-analysis of diagnostic test studies assessing the performance of urinary L-FABP in AKI.
Setting & population: Literature search in MEDLINE, EMBASE, Scopus, Google Scholar, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov using search terms "liver-type fatty acid-binding protein" and "L-FABP."
Selection criteria for studies: Studies of humans investigating the performance characteristics of urinary L-FABP for the early diagnosis of AKI and AKI-related outcomes, including dialysis requirement and mortality.
Predictor: Urinary L-FABP.
Outcomes: Diagnosis of AKI, dialysis requirement, and in-hospital death.
Results: 15 prospective cohort and 2 case-control studies were identified. Only 7 cohort studies could be meta-analyzed. The estimated sensitivity of urinary L-FABP level for the diagnosis of AKI was 74.5% (95% CI, 60.4%-84.8%), and specificity was 77.6% (95% CI, 61.5%-88.2%). The estimated sensitivity of urinary L-FABP level for predicting dialysis requirement was 69.1% (95% CI, 34.6%-90.5%), and specificity was 42.7% (95% CI, 3.1%-94.5%); for in-hospital mortality, sensitivity and specificity were 93.2% (95% CI, 66.2%-99.0%) and 78.8% (95% CI, 27.0%-97.4%), respectively.
Limitations: Paucity and low quality of studies, different clinical settings, and variable definitions of AKI.
Conclusions: Although urinary L-FABP may be a promising biomarker for early detection of AKI and prediction of dialysis requirement and in-hospital mortality, its potential value needs to be validated in large studies and across a broader spectrum of clinical settings.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204–212. - PMC - PubMed
-
- Hospitalization discharge diagnoses for kidney disease--United States, 1980-2005. MMWR Morb Mortal Wkly Rep. 2008 Mar 28;57(12):309–312. - PubMed
-
- Chertow GM, Soroko SH, Paganini EP, et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 2006 Sep;70(6):1120–1126. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
